Otilimab

Tax included
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) humanized monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor.
HY-P99795

Data sheet

Size
Multiple sizes
Reactivity
c-Fms
Application
COVID-19-immunoregulation
CAS
1638332-55-4